Vaccine and Clinical Trials

Vaccine Manufacturing Technologies

Submit Abstract Register Now

The recent vaccine shortages have provided a timely reminder that the world’s vaccine supply has to be increased and the manufacturing issues need to be resolved much faster. The applications of newer technologies in the discovery, development, and production of vaccines have the potential to prevent repeated occurrences of viruses and infectious diseases. Vaccines like Gene-based vaccines, virus-like particles, plant-derived vaccines, and novel adjuvants and delivery systems are very promising and safer for use. More people will have faster access to effective vaccines against a broader spectrum of diseases. However, the increased cost of producing new vaccines and regulatory uncertainty still remains a challenge to vaccine manufacturers.

Related associations and societies: National Institutes of Health (NIH) , Federation of Clinical Immunology Societies (FOCIS), Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), Clinical Immunology Society, Hepatitis B Foundation (HBF), Pediatric Infectious Diseases Society(PIDS), National Institute of Allergy and Infectious Diseases (NIAID), Indian Vaccine Manufacturers Association (IVMA), National Medical Association (NMA), Immune Deficiency Foundation (IDF).